Litigation Details for IN RE: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation (J.P.M.L. 2019)
✉ Email this page to a colleague
IN RE: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation (J.P.M.L. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-01-07 |
Court | United States Judicial Panel on Multidistrict Litigation | Date Terminated | 2020-09-16 |
Cause | Assigned To | Richard G. Andrews | |
Jury Demand | Referred To | ||
Patents | 9,566,289; 9,566,290; 9,572,823 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in IN RE: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Details for IN RE: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation (J.P.M.L. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-04-03 | 50 | Transfer Order - New Litigations | The patents are U.S. Patent No. 9,459,938, U.S. Patent No. 9,566,289, U.S. Patent No. 9,566,290…complex pharmaceutical patents and the entry of generic versions of the patent holder’s drugs are particularly…9,566,290, and U.S. Patent No. 9,572,823. 5 See, e.g., In re: Armodafinil Patent Litig., 755…Brimonidine Patent Litig., 507 F. Supp. 2d 1381 (J.P.M.L. 2007) (same); In re: Metoprolol Succinate Patent Litig…IN RE: KERYDIN (TAVABOROLE) TOPICAL SOLUTION 5% PATENT LITIGATION | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |